ABT — Abbott Laboratories Share News
0.000.00%
Last trade - 00:00- $190.39bn
- $217.85bn
- $44.33bn
Perrigo to sell infant formula business to MeridianMade for up to $175 million
Brief: Abbott Initiates Pivotal Trial For Cephea™ Device, An Innovative Treatment For Mitral Heart Valve Disease
Corrected: German startup NVision shows new path to quantum computing chips in Nature paper
Brief: Abbott Receives FDA Approval For First Device To Treat Leaks After Heart Valve Replacement
Brief: Catheter Precision Announces Publication Of Comparative Study Showing Locket Outperforms Abbott’S Perclose Internal Vascular Closure Device
Street View: Abbott's nutrition spinoff to boost growth
US RESEARCH ROUNDUP-3M, Constellation Energy, Metropolitan Bank
US STOCKS-Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
US STOCKS-Nasdaq leads Wall Street to higher close as SpaceX, Super Micro boost AI sentiment
Nestle, Zydus, Abbott face India scrutiny over claims on children's products (updated)
US STOCKS-Nasdaq climbs over 1% as SpaceX, Super Micro boost AI sentiment
U.S. STOCKS ON THE MOVE-Thermo Fisher, CME, Capital One, Northern Trust
U.S. STOCKS ON THE MOVE-Thermo Fisher, CME
S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT
Nestle, Zydus, Abbott face India scrutiny over claims on children's products
US STOCKS-Nasdaq leads gains as SpaceX, Super Micro results improve AI appetite
U.S. STOCKS ON THE MOVE-Wabtec, Robinhood, NANO Nuclear Energy
Abbott Laboratories reports results for the quarter ended September 30 - Earnings Summary
Brief: Abbott - Appoints Daniel Salvadori As CEO Of New Nutrition Company - SEC Filing